معرفی
Helena Tee is an active academic researcher specializing in psychiatry and mental health interventions. Her work focuses on treatment-resistant depression, psychopharmacology, and clinical trial methodologies. She has contributed to large-scale randomized controlled trials evaluating lithium and quetiapine augmentation therapies, as well as systematic reviews analyzing inflammatory mechanisms in depression treatments. Her research integrates clinical practice with health economics to assess cost-effectiveness of interventions.
Key research areas include antidepressant drug efficacy comparisons, neuroinflammation in depression pathophysiology, and patient perspectives on treatment adherence. Her studies often involve multidisciplinary collaborations and address both pharmacological and non-pharmacological intervention strategies.
Notable contributions include a 2025 Lancet Psychiatry trial comparing lithium vs quetiapine augmentation, and a 2023 systematic review on ketamine and electroconvulsive therapy's inflammatory effects. Her work emphasizes translating neurobiological insights into clinically applicable solutions for treatment-resistant depression.
No specific academic awards are mentioned in the provided materials. Her research consistently addresses critical gaps in understanding and managing severe depressive disorders through rigorous methodological approaches.
